Cargando…
Who may benefit most from future vitamin D intervention trials: do not forget patients on continuous renal replacement therapy
Autores principales: | Honore, Patrick M., Mugisha, Aude, Kugener, Luc, Redant, Sebastien, Attou, Rachid, Gallerani, Andrea, De Bels, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189716/ https://www.ncbi.nlm.nih.gov/pubmed/32345332 http://dx.doi.org/10.1186/s13054-020-02910-w |
Ejemplares similares
-
Vitamin C Dosing During Continuous Renal Replacement Therapy: The Last Word is Not Said!
por: Honore, Patrick M., et al.
Publicado: (2019) -
Austrian recommendations for best clinical practice in case of haemorrhagic traumatic brain injury under platelet inhibitors or non-vitamin K antagonist oral anticoagulants: an additional therapeutic option to consider
por: Honore, Patrick M., et al.
Publicado: (2020) -
Dosing adjuvant vitamin C in critically ill patients undergoing continuous renal replacement therapy: We are not there yet!
por: Honore, Patrick M., et al.
Publicado: (2019) -
Treatment of influenza virus-related critical illness during continuous renal replacement therapy: take caution with dosing
por: Honore, Patrick M., et al.
Publicado: (2020) -
No dose adjustment of tigecycline is necessary during continuous renal replacement therapy: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)